Reports
Sale
Global Rapid Test Kit Market Size, Share, Growth, Forecast: By Type: Rapid Antigen Test, Rapid Antibody Test; By Product Type: Over the counter (OTC) Rapid Test Kit, Professional Rapid Test Kit; By Technology: Lateral Flow Assays, Solid Phase, Agglutination, Others; By Applications; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Rapid Test Kit Market Outlook
The global rapid test kit market size was valued at USD 39.5 billion in 2023, driven by the rise in the geriatric population across the globe. The market size is anticipated to grow at a CAGR of 9.05% during the forecast period of 2024-2032 to achieve a value of USD 86.2 billion by 2032.
Rapid Test Kits: Introduction
Rapid test kits or rapid diagnostics kits are medical test kits which are used as ‘at home detection kits’ for medical conditions or diseases. These test kits are just as convenient and quick as the name suggests. These rapid test kits are used for early or immediate diagnosis of a particular disease or virus, along with enabling the patient to go for timely treatment before things worsen. These rapid test kits can be used by public, healthcare professionals at home, and in healthcare facilities, respectively. These rapid test kits are designed in such a way that they are easy to use and understand, small and convenient, portable, and provide reliable results.
Global Rapid Test Kit Market Analysis
Rapid technological advancements will enable the user to achieve results more quickly and easily. These technological advancements involve the use of new technologies, along with some improved detection methods and reagents to release more accurate and reliable results. Ever since the COVID-19 pandemic happened, the demand for these rapid test kits has skyrocketed. They can be found in every household.
The rapid test kit market demand primarily increased due to the COVID-19 pandemic. These rapid test kits have played a prominent role in explaining the importance of quick self-testing for the symptoms of a disease and take proper precautions accordingly on early basis. The investments in research and development of more accurate at-home rapid testing kits are also increasing. Due to the privacy, accuracy, and convenience they provide, the key players and the governments are highly investing in research and development for developing more test kits for different diseases and symptoms as well.
Global Rapid Test Kit Market Segmentations
Market Breakup by Type
- Rapid Antigen Test
- Rapid Antibody Test
Market Breakup by Product Type
- Over the counter (OTC) Rapid Test Kit
- Professional Rapid Test Kit
Market Breakup by Technology
- Lateral Flow Assays
- Solid Phase
- Agglutination
- Others
Market Breakup by Applications
- Infectious Disease
- COVID-19
- Hepatitis
- HIV
- Influenza
- Others
- Glucose Monitoring
- Pregnancy and Fertility
- Toxicology
- Cardiology
- Oncology
- Lipid Profile Testing
- Others
Market Breakup by End User
- Hospitals and Clinics
- Home Care
- Diagnostic Centres
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Rapid Test Kit Market Overview
The demand for these test kits increased primarily due to the COVID-19 pandemic. The market has also been recording growth lately due to the increasing prevalence of viral infections and other diseases. These rapid test kits are used to diagnose multiple conditions, such as infectious diseases, sexual infections, such as HIV/AIDS, sexually transmitted diseases, and respiratory diseases, among others, leading to the rapid test kit market growth.
The opportunities for growth in the rapid test kits market are endless, due to which the growth of the market has been quite evident. The global rapid test kits market has been growing exponentially in the past and is expected to keep growing during the forecast period as well.
Global Rapid Test Kit Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- F. Hoffmann-La Roche AG
- Abbott Laboratories Ltd
- Danaher Corporation
- Becton, Dickinson and Company
- PerkinElmer, Inc.
- Siemens Healthineers AG
- Thermo Fischer Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- OraSure Technologies, Inc.
- Biomerieux Inc.
- ACON Laboratories, Inc.
- Cellex, Inc.
- MyMD Pharmaceuticals Inc.
- Luminex Corporation
- Eurofins Scientific SE
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Rapid Test Kit Market Overview
3.1 Global Rapid Test Kit Market Historical Value (2017-2023)
3.2 Global Rapid Test Kit Market Forecast Value (2024-2032)
4 Global Rapid Test Kit Market Landscape
4.1 Global Rapid Test Kit Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Rapid Test Kit Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Rapid Test Kit Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Rapid Test Kit Market Segmentation
6.1 Global Rapid Test Kit Market by Type
6.1.1 Market Overview
6.1.2 Rapid Antigen Test
6.1.3 Rapid Antibody Test
6.2 Global Rapid Test Kit Market by Product Type
6.2.1 Market Overview
6.2.2 Over the counter (OTC) Rapid Test Kit
6.2.3 Professional Rapid Test Kit
6.3 Global Rapid Test Kit Market by Technology
6.3.1 Market Overview
6.3.2 Lateral Flow Assays
6.3.3 Solid Phase
6.3.4 Agglutination
6.3.5 Others
6.4 Global Rapid Test Kit Market by Applications
6.4.1 Market Overview
6.4.2 Infectious Disease
6.4.2.1 COVID-19
6.4.2.2 Hepatitis
6.4.2.3 HIV
6.4.2.4 Influenza
6.4.2.5 Others
6.4.3 Glucose Monitoring
6.4.4 Pregnancy and Fertility
6.4.5 Toxicology
6.4.6 Cardiology
6.4.7 Oncology
6.4.8 Lipid Profile Testing
6.4.9 Others
6.5 Global Rapid Test Kit Market by End User
6.5.1 Market Overview
6.5.2 Hospitals and Clinics
6.5.3 Home Care
6.5.4 Diagnostic Centres
6.5.5 Others
6.6 Global Rapid Test Kit Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Rapid Test Kit Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Rapid Test Kit Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Rapid Test Kit Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Rapid Test Kit Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Rapid Test Kit Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 F. Hoffmann-La Roche AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Abbott Laboratories Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Danaher Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Becton, Dickinson and Company
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 PerkinElmer, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Siemens Healthineers AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Thermo Fischer Scientific, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bio-Rad Laboratories, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 OraSure Technologies, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Biomerieux Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 ACON Laboratories, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Cellex, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 MyMD Pharmaceuticals Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Luminex Corporation
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Eurofins Scientific SE
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Rapid Test Kit Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 39.5 billion in 2023.
The market size is anticipated to grow at a CAGR of 9.05% during the forecast period of 2024-2032 and reach a market value of USD 86.2 billion by 2032.
The growth of the market is driven by rising prevalence of infections and diseases, rising awareness about the importance of healthcare, and the rising disposable incomes.
The use of new technologies in the development of rapid test kits is a key trend in the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The types of rapid test kit in the market include rapid antigen test kit and rapid antibody test kit.
The different product types of rapid test kit in the market include over the counter (OTC) rapid test kit and professional rapid test kit.
The different technologies used for rapid test kit include lateral flow assays, solid phase, and agglutination, among others.
The product finds wide applications in infectious disease, glucose monitoring, pregnancy and fertility, toxicology, cardiology, oncology, and lipid profile testing, among others.
The different types of end-users in the rapid test kit include hospitals and clinics, home care, and diagnostic centres, among others.
Key players involved in the market are F. Hoffmann-La Roche AG, Abbott Laboratories Ltd, Danaher Corporation, Becton, Dickinson and Company, PerkinElmer, Inc., Siemens Healthineers AG, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., OraSure Technologies, Inc., Biomerieux Inc., ACON Laboratories, Inc., Inc., MyMD Pharmaceuticals Inc., Luminex Corporation, Eurofins Scientific SE., and Cellex.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER